“Watchlist” is focus of Biotech Showcase 2015 workshop January 13
The Life Sciences Report released their “2015 Small-Cap Biotech Watchlist” on December 18, 2015. The “Watchlist” will be the focus of an expert-led workshop at the upcoming Biotech Showcase life science investor and partnering conference taking place January 12–14, 2015 in San Francisco, CA at Parc 55 Wyndham San Francisco – Union Square.
Now in its third year, the “Watchlist” currently includes 12 drug development companies selected by leading analysts in the sector. With catalysts on the horizon and pipelines that encompass a variety of indications and innovative platforms, these biotechs are primed to return multiples on investment.
Join the panel of experts at Biotech Showcase on Tuesday, January 13 at 8:00 AM moderated by Mara Goldstein, Managing Director, Senior Healthcare Analyst, Cantor Fitzgerald, to hear firsthand why their favorite small-cap ideas are good investment opportunities. The workshop, a must-attend for investors looking for new ideas in the life sciences industry, includes panel experts Reni Benjamin, Managing Director, Equity Research, Analyst, H.C. Wainwright & Co.; Bert Hazlett, Managing Director, Equity Research, Biopharmaceuticals, Ladenburg Thalmann & Co.; Joe Pantginis, Head of Biotechnology Research and Senior Research Analyst, Roth Capital Partners; and George B. Zavoico, Managing Director, Equity Research, MLV & Co.
Read The Life Science Report announcement here.